Australia builds Nobel-prize science. We invest in the companies that carry it to market.
Pre-seed to Series A in Australian deep tech, with structural access into Greater China that no other Australian fund can match.
Building deep tech in Australia?
We back pre-seed to Series A deep-tech founders across biotech, medtech, and new materials & advanced manufacturing — with AI & robotics as a horizontal enabling technology. ESVCLP-eligible, Australian-registered companies only.
Want exposure to top-decile Australian deep tech?
Newton Fund II is open to new wholesale investors. Eoarchean Fund I, our predecessor, sits in the top 10% of its 2021 vintage globally. 10% non-refundable ESVCLP tax offset.
Hello Clever 24.7× · Kite Magnetics 4.6× · Fiable 4.2×
See the portfolio →Eight investments from our 2021 vintage Fund I — five years in. Four have returned above 3× on invested capital. Multiples reported at fair value per IPEV guidelines, Q1 2026.
4.62×
TVPI · Fund I, with 95% of value unrealised
21.5%
Australia has produced 15 Nobel laureates and runs world-class research institutions. Yet it has historically failed to capture the commercial upside — the science travels, the companies don't. The 2020–2027 window, with the A$15B National Reconstruction Fund and fewer than 12 active deep-tech VCs, is the entry point before valuations normalise. Our edge is in the technical due diligence that few Australian funds can run, and in the Greater China commercialisation corridor that no other Australian fund operates directly.
Read the full thesis →From the Boson desk.
All insights →Other Insight
4 Insights For Deep Tech Innovation: The Real Driver of Deep Tech Investment Success
The author shares insights on deep tech startups, arguing that market pull, not technology push, drives innovation success.
Other Insight
Shattering Myths, Building Moats: A Fresh Take on Competitive Advantage
Examining competitive advantage in startups, this article debunks several myths about what truly gives an edge.
Industry Insight
Prospecting Australia-China Bioinnovation Opportunities
Exploring China's biotechnology rise and its implications for Australia, this article highlights potential collaboration opportunities.